{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T17:50:12Z","timestamp":1791481812701,"version":"4.3.4"},"reference-count":70,"publisher":"Walter de Gruyter GmbH","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_jpem-2026-0198_abs_001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Maturity-onset diabetes of the young (MODY) is a heterogeneous monogenic diabetes category caused by defects in genes involved in pancreatic \u03b2-cell development, glucose sensing, or insulin secretion. In children, adolescents, and young adults, its clinical presentation may overlap with type 1 diabetes (T1D) or early-onset type 2 diabetes (T2D), which can complicate etiological classification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jpem-2026-0198_abs_002\">\n                    <jats:title>Content<\/jats:title>\n                    <jats:p>\n                      This review examines continuous glucose monitoring (CGM) patterns in\n                      <jats:italic>HNF1A<\/jats:italic>\n                      -,\n                      <jats:italic>GCK<\/jats:italic>\n                      -,\n                      <jats:italic>HNF4A<\/jats:italic>\n                      -,\n                      <jats:italic>HNF1B<\/jats:italic>\n                      -, and KATP channel-related MODY. PubMed\/MEDLINE, Embase, Web of Science Core Collection, and Scopus were searched through March 1, 2026, with supplementary citation tracking. Priority was given to genetically confirmed or clearly defined studies reporting CGM\/flash glucose monitoring (FGM) metrics, glycemic variability, hypoglycemic exposure, or treatment-transition\u00a0data.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jpem-2026-0198_abs_003\">\n                    <jats:title>Summary and outlook<\/jats:title>\n                    <jats:p>\n                      CGM can complement glycated hemoglobin (HbA\n                      <jats:sub>1c<\/jats:sub>\n                      ) by showing stable mild hyperglycemia, postprandial excursions, nocturnal or asymptomatic hypoglycemia, and treatment-related fluctuations. It should not be used as a substitute for genetic diagnosis. Multicenter, genetically confirmed studies using standardized CGM metrics are needed to clarify its role in precision management.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/jpem-2026-0198","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T03:55:28Z","timestamp":1783914928000},"page":"845-853","source":"Crossref","is-referenced-by-count":0,"title":["Continuous glucose monitoring characteristics of common MODY subtypes and their clinical applications: a review"],"prefix":"10.1515","volume":"39","author":[{"given":"Aibibai","family":"Rouzimaimaiti","sequence":"first","affiliation":[{"name":"Graduate School , Xin Jiang Medical University , Urumqi , Xinjiang Uygur Autonomous Region , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiazireya","family":"Zaiyinati","sequence":"additional","affiliation":[{"name":"Department of Endocrinology , People\u2019s Hospital of Xinjiang Uygur Autonomous Region , Urumqi , Xinjiang , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanrong","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Endocrinology , People\u2019s Hospital of Xinjiang Uygur Autonomous Region , Urumqi , Xinjiang , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuhui","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Endocrinology , People\u2019s Hospital of Xinjiang Uygur Autonomous Region , Urumqi , Xinjiang , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Ma","sequence":"additional","affiliation":[{"name":"Graduate School , Shihezi University , Shihezi , Xinjiang , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism , The Affiliated Hospital of Southwest Medical University , Luzhou , Sichuan , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanying","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Endocrinology , People\u2019s Hospital of Xinjiang Uygur Autonomous Region , Urumqi , Xinjiang , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,7,14]]},"reference":[{"key":"2026100816572546351_j_jpem-2026-0198_ref_001","doi-asserted-by":"crossref","unstructured":"Narasimhegowda, M, Nagarajappa, VH, Palany, R. A case series of maturity-onset diabetes of the young highlighting atypical presentations and the implications of genetic diagnosis. Arch Endocrinol Metab 2024;68:e230239. https:\/\/doi.org\/10.20945\/2359-4292-2023-0239.","DOI":"10.20945\/2359-4292-2023-0239"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_002","doi-asserted-by":"crossref","unstructured":"Aarthy, R, Aston-Mourney, K, Mikocka-Walus, A, Radha, V, Amutha, A, Anjana, RM, et al.. Clinical features, complications and treatment of rarer forms of maturity-onset diabetes of the young (MODY)\u00a0\u2013\u00a0a review. J\u00a0Diabet Complicat 2021;35:107640. https:\/\/doi.org\/10.1016\/j.jdiacomp.2020.107640.","DOI":"10.1016\/j.jdiacomp.2020.107640"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_003","doi-asserted-by":"crossref","unstructured":"Orbe Mu\u00f1oz, L, Bigoni Ord\u00f3\u00f1ez, G. Caracter\u00edsticas de la diabetes del adulto de inicio juvenil y su diagn\u00f3stico en el laboratorio. Revista Vive 2024;7:554\u201370, https:\/\/doi.org\/10.33996\/revistavive.v7i20.322.","DOI":"10.33996\/revistavive.v7i20.322"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_004","doi-asserted-by":"crossref","unstructured":"Toomata, Z, Leask, M, Krishnan, M, Cadzow, M, Dalbeth, N, Stamp, LK, et al.. Genetic testing for misclassified monogenic diabetes in M\u0101ori and Pacific peoples in A\u014dtearoa New\u00a0Zealand with early-onset type 2 diabetes. Front Endocrinol 2023;14:1174699. https:\/\/doi.org\/10.3389\/fendo.2023.1174699.","DOI":"10.3389\/fendo.2023.1174699"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_005","doi-asserted-by":"crossref","unstructured":"Cho, J. Management strategies for children and adolescents with diabetes mellitus. J\u00a0Korean Diabetes 2024;25:145\u20139. https:\/\/doi.org\/10.4093\/jkd.2024.25.3.145.","DOI":"10.4093\/jkd.2024.25.3.145"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_006","doi-asserted-by":"crossref","unstructured":"Tosur, M, Philipson, LH. Precision diabetes: lessons learned from maturity-onset diabetes of the young (MODY). J\u00a0Diabetes Investig 2022;13:1465\u201371. https:\/\/doi.org\/10.1111\/jdi.13860.","DOI":"10.1111\/jdi.13860"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_007","doi-asserted-by":"crossref","unstructured":"Broome, DT, Pantalone, KM, Kashyap, SR, Philipson, LH. Approach to the patient with MODY-monogenic diabetes. J\u00a0Clin Endocrinol Metab 2021;106:237\u201350. https:\/\/doi.org\/10.1210\/clinem\/dgaa710.","DOI":"10.1210\/clinem\/dgaa710"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_008","doi-asserted-by":"crossref","unstructured":"\u00d6zsu, E, \u00c7etinkaya, S, Bolu, S, Hatipo\u011flu, N, Sava\u015f Erdeve, \u015e, Evliyao\u011flu, O, et al.. Clinical and laboratory characteristics of MODY cases, genetic mutation spectrum and phenotype-genotype relationship. J\u00a0Clin Res Pediatr Endocrinol 2024;16:297\u2013305.","DOI":"10.4274\/jcrpe.galenos.2024.2023-10-16"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_009","doi-asserted-by":"crossref","unstructured":"Deng, L, Shah, AS, Krishnamurthy, M. Genetic variants and characterization of MODY in a single, large pediatric referral center. J\u00a0Clin Transl Endocrinol 2025;40:100398. https:\/\/doi.org\/10.1016\/j.jcte.2025.100398.","DOI":"10.1016\/j.jcte.2025.100398"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_010","doi-asserted-by":"crossref","unstructured":"Ren, Q, Zhang, P, Pang, W, Ma, Y, Gong, S, Ba, T, et al.. A comparison of daily glucose fluctuation between GCK-MODY and type 2 diabetes using continuous glucose monitoring technology. Diabetes 2023;72:812\u20138. https:\/\/doi.org\/10.2337\/db22-0566.","DOI":"10.2337\/db22-0566"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_011","doi-asserted-by":"crossref","unstructured":"Hul\u00edn, J, \u0160kopkov\u00e1, M, Valkovi\u010dov\u00e1, T, Mikulajov\u00e1, S, Roso\u013eankov\u00e1, M, Papcun, P, et al.. Clinical implications of the glucokinase impaired function - GCK MODY today. Physiol Res 2020;69:995\u20131011. https:\/\/doi.org\/10.33549\/physiolres.934487.","DOI":"10.33549\/physiolres.934487"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_012","doi-asserted-by":"crossref","unstructured":"Wang, T, Zhu, M, Wang, Y, Hu, C, Fang, C, Hu, J. Two novel GCK mutations in Chinese patients with maturity-onset diabetes of the young. Endocrine 2024;83:92\u20138. https:\/\/doi.org\/10.1007\/s12020-023-03509-1.","DOI":"10.1007\/s12020-023-03509-1"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_013","doi-asserted-by":"crossref","unstructured":"Grennan, KN, Singh, D, Chindris, AM, Wilson, JR. A case of oral semaglutide for treatment of hepatocyte nuclear factor 4A maturity-onset diabetes of the young. AACE Endocrinol Diabetes 2026;13:177\u20139. https:\/\/doi.org\/10.1016\/j.aed.2025.12.002.","DOI":"10.1016\/j.aed.2025.12.002"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_014","doi-asserted-by":"crossref","unstructured":"Zhao, Q, Ding, L, Yang, Y, Sun, J, Wang, M, Li, X, et al.. Clinical characteristics of patients with HNF1-alpha MODY: a literature review and retrospective chart review. Front Endocrinol 2022;13:900489. https:\/\/doi.org\/10.3389\/fendo.2022.900489.","DOI":"10.3389\/fendo.2022.900489"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_015","doi-asserted-by":"crossref","unstructured":"Steenkamp, DW, Cheney, MC, Ju, Z, Rodbard, D, Wolpert, HA. Proof-of-concept application of continuous glucose monitoring data analytics to identify diabetes glucotypes. J\u00a0Endocr Soc 2023;7:bvad038. https:\/\/doi.org\/10.1210\/jendso\/bvad038.","DOI":"10.1210\/jendso\/bvad038"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_016","doi-asserted-by":"crossref","unstructured":"Rymar, O, Mustafina, S, Ovsyannikova, A, Shakhtshneider, E, Ivanoshchuk, D, Ruzaeva, E, et al.. ABCC8-associated with maturity-onset diabetes in a young woman: clinical features and genetic analysis. Sib Nauchn Med Zh 2026;45:279\u201385. https:\/\/doi.org\/10.18699\/ssmj20250628.","DOI":"10.18699\/SSMJ20250628"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_017","doi-asserted-by":"crossref","unstructured":"Almutair, A, Almulhem, B. Semaglutide as a potential therapeutic alternative for HNF1B-MODY: a case study. Front Endocrinol 2024;15:1294264. https:\/\/doi.org\/10.3389\/fendo.2024.1294264.","DOI":"10.3389\/fendo.2024.1294264"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_018","doi-asserted-by":"crossref","unstructured":"Lyra, A, Ferreira, FR, Mois\u00e9s, RCS, de Noronha, RM, Calliari, LE. The role of intermittent continuous glucose monitoring in a successful outpatient transition from insulin to glibenclamide in a patient with transient neonatal diabetes. Arch Endocrinol Metab 2022;66:429\u201335.","DOI":"10.20945\/2359-3997000000484"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_019","doi-asserted-by":"crossref","unstructured":"Bao, Y, Chen, L, Chen, L, Dou, J, Gao, Z, Gao, L, et al.. Chinese clinical guidelines for continuous glucose monitoring (2018 edition). Diabetes Metab Res Rev 2019;35:e3152. https:\/\/doi.org\/10.1002\/dmrr.3152.","DOI":"10.1002\/dmrr.3152"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_020","doi-asserted-by":"crossref","unstructured":"Bao, Y, Zhu, D. Clinical application guidelines for blood glucose monitoring in China (2022 edition). Diabetes Metab Res Rev 2022;38:e3581. https:\/\/doi.org\/10.1002\/dmrr.3581.","DOI":"10.1002\/dmrr.3581"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_021","doi-asserted-by":"crossref","unstructured":"Tagawa, K, Matsui, K, Tsukamura, A, Shibata, M, Tsutsui, H, Nagai, S, et al.. Use of a long-term continuous glucose monitor for predicting sulfonylurea dose in patients with neonatal diabetes mellitus: a case series. Clin Pediatr Endocrinol 2024;33:131\u20138. https:\/\/doi.org\/10.1297\/cpe.2023-0062.","DOI":"10.1297\/cpe.2023-0062"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_022","doi-asserted-by":"crossref","unstructured":"Kwon, SY, Moon, JS. Advances in continuous glucose monitoring: clinical applications. Endocrinol Metab 2025;40:161\u201373. https:\/\/doi.org\/10.3803\/enm.2025.2370.","DOI":"10.3803\/EnM.2025.2370"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_023","doi-asserted-by":"crossref","unstructured":"Klonoff, DC, Ahn, D, Drincic, A. Continuous glucose monitoring: a review of the technology and clinical use. Diabetes Res Clin Pract 2017;133:178\u201392. https:\/\/doi.org\/10.1016\/j.diabres.2017.08.005.","DOI":"10.1016\/j.diabres.2017.08.005"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_024","doi-asserted-by":"crossref","unstructured":"Chernikova, N. Evolution of continuous glucose monitoring in existing clinical guidelines for patient with diabetes mellitus. Endocrinol News, Opinions, Training 2020;9:59\u201365. https:\/\/doi.org\/10.33029\/2304-9529-2020-9-4-59-65.","DOI":"10.33029\/2304-9529-2020-9-4-59-65"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_025","doi-asserted-by":"crossref","unstructured":"Ovsyannikova, A, Dudina, M, Galenok, R, Antonova, A, Rymar, O. Characteristics of glucose variability in different types of diabetes mellitus in young patients. Medicinskij sovet 2023;17:74\u201380. https:\/\/doi.org\/10.21518\/ms2023-160.","DOI":"10.21518\/ms2023-160"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_026","doi-asserted-by":"crossref","unstructured":"Qureshi, M, Nawaz, R. Maturity onset diabetes of the young. InnovAIT 2021;14:669\u201375. https:\/\/doi.org\/10.1177\/17557380211039537.","DOI":"10.1177\/17557380211039537"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_027","doi-asserted-by":"crossref","unstructured":"Mozzillo, E, Salzano, G, Barbetti, F, Maffeis, C, Lombardo, F, Franzese, A, et al.. Survey on etiological diagnosis of diabetes in 1244 Italian diabetic children and adolescents: impact of access to genetic testing. Diabetes Res Clin Pract 2015;107:e15\u20138. https:\/\/doi.org\/10.1016\/j.diabres.2015.01.003.","DOI":"10.1016\/j.diabres.2015.01.003"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_028","doi-asserted-by":"crossref","unstructured":"Hasballa, I, Maggi, D. MODY only monogenic? a narrative review of the novel rare and low-penetrant variants. Int J Mol Sci 2024;25. https:\/\/doi.org\/10.3390\/ijms25168790.","DOI":"10.3390\/ijms25168790"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_029","doi-asserted-by":"crossref","unstructured":"Garg, RK. MODY: strategies for a unique form of diabetes. J\u00a0Educ Health Promot 2025;14:338. https:\/\/doi.org\/10.4103\/jehp.jehp_1880_24.","DOI":"10.4103\/jehp.jehp_1880_24"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_030","doi-asserted-by":"crossref","unstructured":"Horikawa, Y, Hosomichi, K, Yabe, D. Monogenic diabetes. Diabetol Int 2024;15:679\u201387. https:\/\/doi.org\/10.1007\/s13340-024-00698-6.","DOI":"10.1007\/s13340-024-00698-6"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_031","doi-asserted-by":"crossref","unstructured":"P\u00e9rez L\u00f3pez, P, Bahillo Curieses, P, Fern\u00e1ndez, P, Mart\u00ednez, R, Delgado, E, Ortol\u00e1, A, et al.. Clinical, glycometric features and treatment in a family with monogenic diabetes due to a new mutation in the insulin gene. Endocrinol Diabetes Nutr (Engl Ed) 2024;71:77\u201382. https:\/\/doi.org\/10.1016\/j.endien.2024.03.006.","DOI":"10.1016\/j.endien.2024.03.006"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_032","doi-asserted-by":"crossref","unstructured":"Delvecchio, M, Liu, M, Rapini, N, Barbetti, F. Editorial: personalized therapies for monogenic diabetes. Front Genet 2024;15:1496367. https:\/\/doi.org\/10.3389\/fgene.2024.1496367.","DOI":"10.3389\/fgene.2024.1496367"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_033","doi-asserted-by":"crossref","unstructured":"Ga\u00e1l, Z, Balogh, I. Monogenic forms of diabetes mellitus. Exper Suppl (Basel) 2019;111:385\u2013416.","DOI":"10.1007\/978-3-030-25905-1_18"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_034","doi-asserted-by":"crossref","unstructured":"Barbetti, F, D\u2019Annunzio, G. Genetic causes and treatment of neonatal diabetes and early childhood diabetes. Best Pract Res Clin Endocrinol Metabol 2018;32:575\u201391. https:\/\/doi.org\/10.1016\/j.beem.2018.06.008.","DOI":"10.1016\/j.beem.2018.06.008"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_035","doi-asserted-by":"crossref","unstructured":"Dusatkova, P, Pavlikova, M, Cermakova, M, Vesela, K, Kolarova, K, Elblova, L, et al.. High prevalence of maturity-onset diabetes of the young in the Czech Republic: a 25-year nationwide registry-based study. Diabet Med 2026;43:e70279. https:\/\/doi.org\/10.1111\/dme.70279.","DOI":"10.1111\/dme.70279"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_036","doi-asserted-by":"crossref","unstructured":"Liu, J, Xiao, X, Zhang, Q, Yu, M. Insights from basic adjunctive examinations of GCK-MODY, HNF1A-MODY, and type 2 diabetes: a systemic review and meta-analysis. J\u00a0Diabetes 2023;15:519\u201331. https:\/\/doi.org\/10.1111\/1753-0407.13390.","DOI":"10.1111\/1753-0407.13390"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_037","doi-asserted-by":"crossref","unstructured":"Christensen, AS, H\u00e6dersdal, S, St\u00f8y, J, Storgaard, H, Kampmann, U, Forman, JL, et al.. Efficacy and safety of glimepiride with or without linagliptin treatment in patients with HNF1A diabetes (maturity-onset diabetes of the young type 3): a randomized, double-blinded, placebo-controlled, crossover trial (GLIMLINA). Diabetes Care 2020;43:2025\u201333. https:\/\/doi.org\/10.2337\/dc20-0408.","DOI":"10.2337\/dc20-0408"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_038","doi-asserted-by":"crossref","unstructured":"Gifford, RM, Foteinopoulou, E, Strachan, MWJ. Please see this man with a 69-year history of hypoglycaemia. J\u00a0R Coll Physicians Edinb 2021;51:266\u20138. https:\/\/doi.org\/10.4997\/jrcpe.2021.312.","DOI":"10.4997\/jrcpe.2021.312"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_039","doi-asserted-by":"crossref","unstructured":"Bacon, S, Kyithar, MP, Condron, EM, Vizzard, N, Burke, M, Byrne, MM. Prolonged episodes of hypoglycaemia in HNF4A-MODY mutation carriers with IGT. Evidence of persistent hyperinsulinism into early adulthood. Acta Diabetol 2016;53:965\u201372. https:\/\/doi.org\/10.1007\/s00592-016-0890-9.","DOI":"10.1007\/s00592-016-0890-9"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_040","doi-asserted-by":"crossref","unstructured":"Gon\u00e7alves, J, Ferreira, HU, Ribeiro, S, Fernandes da Rocha, D, Souto, SB, Pedro, J, et al.. Challenges in diagnosis and treatment of KCNJ11-MODY. Endocrinol Diabetes Metab Case Rep 2024;2024. https:\/\/doi.org\/10.1530\/EDM-24-0048.","DOI":"10.1530\/EDM-24-0048"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_041","doi-asserted-by":"crossref","unstructured":"Ovsyannikova, AK, Rymar, OD, Shakhtshneider, EV, Klimontov, VV, Koroleva, EA, Myakina, NE, et al.. ABCC8-Related maturity-onset diabetes of the young (MODY12): clinical features and treatment perspective. Diabetes Ther 2016;7:591\u2013600. https:\/\/doi.org\/10.1007\/s13300-016-0192-9.","DOI":"10.1007\/s13300-016-0192-9"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_042","doi-asserted-by":"crossref","unstructured":"Ovsyannikova, A, Dudina, M, Dolinskaya, Y, Rymar, O. Characteristics of glycemic variability in patients with GCK-MODY. Arhiv Vnutrennej Mediciny 2022;12:467\u201372. https:\/\/doi.org\/10.20514\/2226-6704-2022-12-6-467-472.","DOI":"10.20514\/2226-6704-2022-12-6-467-472"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_043","doi-asserted-by":"crossref","unstructured":"Gardner, DS, Rama Chandran, S, Sng, GGR, Carmody, D. Continuous glucose monitoring in glucokinase-maturity-onset diabetes of the young pregnancy: a treatment paradigm change. JCEM Case Rep 2025;3:luaf147. https:\/\/doi.org\/10.1210\/jcemcr\/luaf147.","DOI":"10.1210\/jcemcr\/luaf147"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_044","doi-asserted-by":"crossref","unstructured":"Colclough, K, van Heugten, R, Patel, K. An update on the diagnosis and management of monogenic diabetes. Pract Diabetes 2022;39:42\u20138. https:\/\/doi.org\/10.1002\/pdi.2410.","DOI":"10.1002\/pdi.2410"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_045","doi-asserted-by":"crossref","unstructured":"Kong, APS, Lim, S, Yoo, SH, Ji, L, Chen, L, Bao, Y, et al.. Asia-Pacific consensus recommendations for application of continuous glucose monitoring in diabetes management. Diabetes Res Clin Pract 2023;201:110718. https:\/\/doi.org\/10.1016\/j.diabres.2023.110718.","DOI":"10.1016\/j.diabres.2023.110718"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_046","doi-asserted-by":"crossref","unstructured":"Lee, GS, Lupsa, BC. Continuous glucose monitoring for the internist. Med Clin 2021;105:967\u201382. https:\/\/doi.org\/10.1016\/j.mcna.2021.06.004.","DOI":"10.1016\/j.mcna.2021.06.004"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_047","doi-asserted-by":"crossref","unstructured":"Gong, X, Zhang, L, Ma, Q, Zhang, Y, Hu, K, Jiang, H, et al.. Functional validation of a non-canonical HNF1B splice-site variant in MODY5. Front Endocrinol 2026;17:1777094. https:\/\/doi.org\/10.3389\/fendo.2026.1777094.","DOI":"10.3389\/fendo.2026.1777094"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_048","doi-asserted-by":"crossref","unstructured":"Kavvoura, F, Owen, K. Diagnosis and management of monogenic diabetes. Medicine (Abingdon) 2022;50:632\u20137. https:\/\/doi.org\/10.1016\/j.mpmed.2022.07.004.","DOI":"10.1016\/j.mpmed.2022.07.004"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_049","doi-asserted-by":"crossref","unstructured":"Radha, V, Mohan, V. Genetic basis of monogenic diabetes. Curr Sci 2017;113:1277. https:\/\/doi.org\/10.18520\/cs\/v113\/i07\/1277-1286.","DOI":"10.18520\/cs\/v113\/i07\/1277-1286"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_050","doi-asserted-by":"crossref","unstructured":"Deng, L, Lanzinger, S, Casteels, K, Cavallo, F, De Sanctis, L, Fitas, AL, et al.. A worldwide perspective on clinical characteristics and treatment of youth with monogenic diabetes in the SWEET registry. J\u00a0Endocr Soc 2026;10:bvag064. https:\/\/doi.org\/10.1210\/jendso\/bvag064.","DOI":"10.1210\/jendso\/bvag064"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_051","doi-asserted-by":"crossref","unstructured":"Murphy, R, Colclough, K, Pollin, TI, Ikle, JM, Svalastoga, P, Maloney, KA, et al.. The use of precision diagnostics for monogenic diabetes: a systematic review and expert opinion. Commun Med 2023;3:136. https:\/\/doi.org\/10.1038\/s43856-023-00369-8.","DOI":"10.1101\/2023.04.15.23288269"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_052","doi-asserted-by":"crossref","unstructured":"Auble, B, Dey, J. Monogenetic etiologies of diabetes. Med Clin 2024;108:15\u201326. https:\/\/doi.org\/10.1016\/j.mcna.2023.05.013.","DOI":"10.1016\/j.mcna.2023.05.013"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_053","doi-asserted-by":"crossref","unstructured":"Billings, LK, Shi, Z, Resurreccion, WK, Wang, CH, Wei, J, Pollin, TI, et al.. Statistical evidence for high-penetrance MODY-causing genes in a large population-based cohort. Endocrinol Diabetes Metab 2022;5:e372. https:\/\/doi.org\/10.1002\/edm2.372.","DOI":"10.1002\/edm2.372"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_054","doi-asserted-by":"crossref","unstructured":"Marassi, M, Morieri, ML, Sanga, V, Ceolotto, G, Avogaro, A, Fadini, GP. The elusive nature of ABCC8-related maturity-onset diabetes of the young (ABCC8-MODY). A review of the literature and case discussion. Curr Diabetes Rep 2024;24:197\u2013206. https:\/\/doi.org\/10.1007\/s11892-024-01547-1.","DOI":"10.1007\/s11892-024-01547-1"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_055","doi-asserted-by":"crossref","unstructured":"Rebec, M, Cai, K, Dutt-Ballerstadt, R, Anderson, E. A prospective multicenter clinical performance evaluation of the C-CGM system. J\u00a0Diabetes Sci Technol 2022;16:390\u20136. https:\/\/doi.org\/10.1177\/1932296820964574.","DOI":"10.1177\/1932296820964574"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_056","doi-asserted-by":"crossref","unstructured":"L\u00f3pez Tinoco, C, S\u00e1nchez, LB, Bacon, S, Colclough, K, Ng, N, Wong, E, et al.. Evaluation of pregnancy outcomes in women with GCK-MODY. Diabet Med 2021;38:e14488. https:\/\/doi.org\/10.1111\/dme.14488.","DOI":"10.1111\/dme.14488"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_057","doi-asserted-by":"crossref","unstructured":"Sotiriou, G, Xinias, S, Diamantidou, V, Mertzanian, A, Dimitriadou, M, Sertedaki, A, et al.. Diazoxide and continuous glucose monitoring as treatment in a neonate with hyperinsulinemic hypoglycemia due to HNF4A mutation. J\u00a0Clin Res Pediatr Endocrinol 2025. [Epub ahead of print] https:\/\/doi.org\/10.4274\/jcrpe.galenos.2025.2025-4-12.","DOI":"10.4274\/jcrpe.galenos.2025.2025-4-12"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_058","doi-asserted-by":"crossref","unstructured":"Mehdi, AZ, Deng, L, Chase, CL, Foss-Freitas, MC, Gregg, B, Naylor, RN, et al.. GLP-1 RA and dual GIP\/GLP-1 RA treatment in MODY: a descriptive case series. BMJ Open Diabetes Res Care 2025;13. https:\/\/doi.org\/10.1136\/bmjdrc-2024-004885.","DOI":"10.1136\/bmjdrc-2024-004885"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_059","doi-asserted-by":"crossref","unstructured":"Reilly, F, Sanchez-Lechuga, B, Clinton, S, Crowe, G, Burke, M, Ng, N, et al.. Phenotype, genotype and glycaemic variability in people with activating mutations in the ABCC8 gene: response to appropriate therapy. Diabet Med 2020;37:876\u201384. https:\/\/doi.org\/10.1111\/dme.14145.","DOI":"10.1111\/dme.14145"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_060","doi-asserted-by":"crossref","unstructured":"Szopa, M, Matejko, B, Ucieklak, D, Uchman, A, Hohendorff, J, Mrozi\u0144ska, S, et al.. Quality of life assessment in patients with HNF1A-MODY and GCK-MODY. Endocrine 2019;64:246\u201353. https:\/\/doi.org\/10.1007\/s12020-018-1812-0.","DOI":"10.1007\/s12020-018-1812-0"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_061","doi-asserted-by":"crossref","unstructured":"Lanning, MS, Carmody, D, Szczerbi\u0144ski, \u0141, Letourneau, LR, Naylor, RN, Greeley, SAW. Hypoglycemia in sulfonylurea-treated KCNJ11-neonatal diabetes: mild-moderate symptomatic episodes occur infrequently but none involving unconsciousness or seizures. Pediatr Diabetes 2018;19:393\u20137. https:\/\/doi.org\/10.1111\/pedi.12599.","DOI":"10.1111\/pedi.12599"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_062","doi-asserted-by":"crossref","unstructured":"Lameijer, A, Fokkert, MJ, Edens, MA, Slingerland, RJ, Bilo, HJG, van Dijk, PR. Determinants of HbA1c reduction with FreeStyle libre flash glucose monitoring (FLARE-NL 5). J\u00a0Clin Transl Endocrinol 2020;22:100237. https:\/\/doi.org\/10.1016\/j.jcte.2020.100237.","DOI":"10.1016\/j.jcte.2020.100237"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_063","doi-asserted-by":"crossref","unstructured":"Reddy, T, Bhattacharyya, S. A case series of maturity onset diabetes of the young: searching for a polar bear in a snowstorm. KPJ 2024;39:51\u20133. https:\/\/doi.org\/10.25259\/kpj_20_2024.","DOI":"10.25259\/KPJ_20_2024"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_064","doi-asserted-by":"crossref","unstructured":"Aloi, C, Salina, A, Cappato, S, Minuto, N, D\u2019Annunzio, G, Gotta, F, et al.. Deciphering silence: functional studies of GCK synonymous and nonsense variants and their importance in understanding diabetes. Genes 2026;17. https:\/\/doi.org\/10.3390\/genes17020214.","DOI":"10.3390\/genes17020214"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_065","doi-asserted-by":"crossref","unstructured":"Cheon, CK, Lee, YJ, Yoo, S, Lee, JH, Lee, JE, Kim, HJ, et al.. Delineation of the genetic and clinical spectrum, including candidate genes, of monogenic diabetes: a multicenter study in South Korea. J\u00a0Pediatr Endocrinol Metab 2020;33:1539\u201350. https:\/\/doi.org\/10.1515\/jpem-2020-0336.","DOI":"10.1515\/jpem-2020-0336"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_066","doi-asserted-by":"crossref","unstructured":"Mancioppi, V, Pozzi, E, Zanetta, S, Missineo, A, Savastio, S, Barbetti, F, et al.. Case report: better late than never, but sooner is better: switch from CSII to sulfonylureas in two patients with neonatal diabetes due to KCNJ11 variants. Front Endocrinol 2023;14:1143736. https:\/\/doi.org\/10.3389\/fendo.2023.1143736.","DOI":"10.3389\/fendo.2023.1143736"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_067","doi-asserted-by":"crossref","unstructured":"Jin, S 2023 Clinical practice guidelines for diabetes: continuous glucose\u00a0monitoring and insulin pumps. J\u00a0Korean Diabetes 2023;24:141\u20137, https:\/\/doi.org\/10.4093\/jkd.2023.24.3.141.","DOI":"10.4093\/jkd.2023.24.3.141"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_068","doi-asserted-by":"crossref","unstructured":"Sierra, JA, Shah, M, Gill, MS, Flores, Z, Chawla, H, Kaufman, FR, et al.. Clinical and economic benefits of professional CGM among people with type 2 diabetes in the United\u00a0States: analysis of claims and lab data. J\u00a0Med Econ 2018;21:225\u201330. https:\/\/doi.org\/10.1080\/13696998.2017.1390474.","DOI":"10.1080\/13696998.2017.1390474"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_069","doi-asserted-by":"crossref","unstructured":"Frank, J, Son, D, Szafranski, K, Poon, Y. Continuous glucose monitoring for self-management of diabetes in people living with type 2 diabetes mellitus on basal insulin therapy: a microsimulation model and cost-effectiveness analysis from a US perspective with relevance to medicaid. J\u00a0Manag Care Spec Pharm 2024;30:917\u201328. https:\/\/doi.org\/10.18553\/jmcp.2024.24025.","DOI":"10.18553\/jmcp.2024.24025"},{"key":"2026100816572546351_j_jpem-2026-0198_ref_070","doi-asserted-by":"crossref","unstructured":"Ni, K, Tampe, CA, Sol, K, Richardson, DB, Pereira, RI. Effect of CGM access expansion on uptake among patients on medicaid with diabetes. Diabetes Care 2023;46:391\u20138. https:\/\/doi.org\/10.2337\/dc22-1287.","DOI":"10.2337\/dc22-1287"}],"container-title":["Journal of Pediatric Endocrinology and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpem-2026-0198\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpem-2026-0198\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:57:57Z","timestamp":1791478677000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpem-2026-0198\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,14]]},"references-count":70,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,6,24]]},"published-print":{"date-parts":[[2026,9,25]]}},"alternative-id":["10.1515\/jpem-2026-0198"],"URL":"https:\/\/doi.org\/10.1515\/jpem-2026-0198","relation":{},"ISSN":["0334-018X","2191-0251"],"issn-type":[{"value":"0334-018X","type":"print"},{"value":"2191-0251","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,14]]}}}